It is possible that cancer progression and PD-L1 protein expression are independently related to the PTEN loss in cancer cells, and the clinical effect of PD-L1 may be, at least in part, attributed to an association between PTEN loss and PD-L1 expression. The gene discussed is PTEN; the disease is cancer.